Anemoi Biotech Holdings Inc
Research - Ames, Iowa, United States
Anemoi Biotech Holdings Inc Employees
Anemoi Biotech Holdings Inc Details
Anemoi offers the first cross-disciplinary approach to the treatment of viral respiratory infections (VRIs). The lungs are the route of entry and primary organs damaged by respiratory viruses. Anemoi's prophylactic and therapeutic platforms directly treat the lungs. Our team of world-class scientists has a combined 85 years of experience in inflammation, immunology, and vaccine development. Anemoi has patents pending that will grant protection through 2040. Anemoi holds IP and strategic collaborative positions around the production of therapeutic molecules, the use of carrier platforms, and the use of a T cell-activating, broad-spectrum vaccine technology.
Anemoi Biotech Holdings Inc Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Hosting
GoDaddy Hosting
Other
Mobile Friendly